Do You Regain Weight After Stopping Semaglutide or Tirzepatide?
Do you regain weight after stopping Semaglutide or Tirzepatide?
Yes, most people regain a meaningful share of lost weight after stopping a GLP-1, because the medication manages a chronic condition and appetite signals return when it is withdrawn. This is expected, not a failure. An MD-managed maintenance dose or careful taper, paired with protein and strength training, helps protect long-term results. Individual results vary.
Let's answer the hard question honestly
The single most common question I hear before someone starts a GLP-1 is some version of: "If I stop, does it all come back?" It's the right question, and you deserve a straight answer instead of a sales pitch.
I'm Dr. Keisha Bryant, a board-certified internal medicine physician in St Albans, Queens. Here is the honest version: for most people, stopping the medication abruptly does lead to meaningful weight regain. That is not a flaw in you and it is not the medication "failing." It is exactly what we'd expect when you treat a chronic condition and then remove the treatment.
I'd rather you hear this from me up front than be surprised later. Understanding why it happens is what lets us plan around it.
Why weight comes back — the actual biology
Obesity and stubborn weight are not simply a question of willpower. The body defends a "set point" using hormones that regulate hunger and fullness. Medications like Semaglutide — the same active ingredient as Ozempic and Wegovy — and Tirzepatide — the same active ingredient as Mounjaro and Zepbound — work by mimicking gut hormones (GLP-1, and GIP as well for tirzepatide) that:
- Quiet appetite and "food noise" — the constant background pull toward food.
- Slow stomach emptying, so you feel full sooner and longer.
- Improve how your body handles blood sugar and insulin.
Here's the part that matters for your question: the medication manages these signals while you take it. It does not permanently reset your biology. When you stop, the medication clears your system, and within weeks the original appetite signals return. Hunger comes back, fullness fades faster, and "food noise" gets louder again. For most people, eating naturally increases, and some of the lost weight follows.
Think of it the way we think about blood pressure medication. If a patient's blood pressure is controlled on medication and they stop, the pressure usually rises again. We don't call that a failure of the drug — we recognize we're managing a chronic condition. Weight regulation works much the same way.
What the research actually shows
I'll give you real numbers, with the honesty they deserve.
| Program | Medication | Average loss on treatment | What withdrawal studies suggest |
|---|---|---|---|
| STEP program | Semaglutide | ~10–15% of body weight over ~12 months | A large share of lost weight regained over the year after stopping |
| SURMOUNT program | Tirzepatide | ~15–22% over 72 weeks | Substantial regain after withdrawal; continued treatment preserves more of the loss |
When semaglutide was withdrawn in a controlled study, participants regained a large portion of the weight they had lost over the following year, while those who continued treatment largely maintained their results. Tirzepatide withdrawal studies point the same direction: staying on treatment preserved the loss, while stopping led to significant regain.
Individual results vary. Figures are clinical-trial averages; they are not a guarantee of individual results. But the pattern is consistent and well documented, and I won't pretend otherwise.
So is the medication "permanent"?
Not necessarily — and this is where good MD care matters. The goal is not to keep you on the highest dose forever by default. The goal is durable results with the least medication that maintains them. In practice, after you reach a healthy weight, we typically choose between:
- A maintenance dose. Many patients stay on a lower, steady dose long term to hold their results — the same way we'd continue a blood-pressure or thyroid medication for a chronic condition.
- A careful taper. For some patients, we step the dose down slowly while reinforcing habits, and watch closely for early regain so we can adjust before it accelerates.
- Stopping with a structured plan, for patients whose situation supports it — with a clear plan to re-engage if appetite and weight climb back.
There is no one-size-fits-all answer. What's right depends on your starting point, your health conditions, how your body responds, and your goals. That decision is made with a physician — not by a website or a 30-day refill that simply runs out.
How we protect your results — and why MD supervision matters
The patients who keep their results are rarely the ones who relied on the medication alone. At Dr. Bryant Medical, every weight-loss patient is supervised by Dr. Keisha Bryant, MD, with monthly check-ins, gradual dose titration, and lab monitoring. Here's what that buys you for the long game:
- We protect muscle while you lose fat. Adequate protein and strength training 2–3x/week preserve the metabolically active tissue that keeps regain at bay. Rapid loss without this is the fastest route to rebound.
- *We build habits during treatment,* while the medication makes a sustainable diet realistic instead of a daily battle — so the routine is already in place if we taper.
- We monitor labs and dose deliberately. Dr. Bryant titrates slowly so we find the lowest effective dose, not just the highest.
- We catch regain early. Monthly contact means if the scale or appetite starts to climb, we adjust the plan before it becomes a setback.
A telehealth refill service that never sees your bloodwork and never follows up can't do any of this — which is part of why "stopped and gained it all back" stories are so common.
Talk to us first if
Before starting any GLP-1, we screen carefully. Please tell us — and talk to us first — if any of these apply to you:
- You are pregnant, planning pregnancy, or breastfeeding.
- You have a personal or family history of medullary thyroid cancer, or MEN2 (multiple endocrine neoplasia type 2).
- You have a history of pancreatitis.
- You take medications that may interact, including insulin or other diabetes medications.
These aren't fine print — they're why a GLP-1 belongs with a board-certified MD and not an anonymous online checkout.
Side effects, honestly
The most common side effects are mild nausea, indigestion, and constipation, and they usually show up during dose increases. For most people they ease within about a week. To keep this manageable, Dr. Bryant titrates the dose slowly over roughly 4–8 weeks rather than rushing. We use FDA-approved medication from a licensed U.S. pharmacy — never compounded-online or drop-shipped product of unknown origin.
Are you a candidate?
GLP-1 therapy is generally appropriate for adults with:
- A BMI of 30 or higher, or
- A BMI of 27 or higher with a weight-related condition such as type 2 diabetes, high blood pressure, or sleep apnea.
BMI is a screening tool, not a diagnosis. Final eligibility is decided by the MD at your free 15-minute consult, where we review your history, goals, and labs. You can read more on our medical weight loss page, or compare the two medications directly: Semaglutide and Tirzepatide. New to all of this? Here's what to expect at your first weight-loss visit.
What it costs — all-inclusive
No surprise add-ons. Our pricing is $199/mo (Semaglutide) and $250/mo (Tirzepatide), all-inclusive — it covers medication, monthly MD check-in, dose titration, labs, unlimited messaging, and a nutrition plan. That ongoing support is precisely what makes durable, MD-managed maintenance possible.
Dr. Bryant's bottom line
If you take one thing from this: regain after stopping is a known clinical reality, not a personal failure. You are managing a chronic condition, and like most chronic conditions, it responds to ongoing care. The patients who keep their results treat the medication as one tool inside a supervised plan — with protein, strength training, monthly follow-up, and a thoughtful decision about maintenance versus tapering made with a physician.
If you're in Queens and want a plan built around your labs and your life — including a clear long-term strategy from day one — we'd love to help. Visit us at 205-15 Hollis Avenue, St Albans, NY 11412, call +1 (718) 217-3744 (Mon–Sat, 9–5), or book a free 15-minute consult.
Note: This article is educational and not medical advice. GLP-1 medications are prescribed only within a physician-patient relationship after screening. Individual results vary.
Frequently asked questions
Will I regain weight if I stop Semaglutide or Tirzepatide?
Do I have to take a GLP-1 forever?
Why does the weight come back after stopping?
How can I keep the weight off long term?
Is a maintenance dose safe to stay on?
What does it cost, and is follow-up included?
Ready to talk to a real MD?
Book a free 15-minute consult with Dr. Bryant in St Albans, Queens. Real screening, real conversation, no sales pressure.
Book Free ConsultContinue reading
All articlesOzempic vs Wegovy: What's the Difference? (Same Drug, Explained by a Queens MD)
Ozempic and Wegovy are two brand names for the exact same active ingredient — semaglutide. A board-certified Queens MD explains why there are two names, how the FDA approvals and max doses differ, what it means for weight loss, and how a cash-pay program fits.
Why Obesity Hits Harder in Black Communities — and What Actually Helps
Obesity isn't a willpower problem — it's a chronic disease with biological and social drivers, and it carries higher diabetes, heart, and blood-pressure risk in Black communities. A Black female MD in Queens explains why, without scare tactics or shame, and what genuinely lowers that risk.